Indian Essential Drugs List Heralds Price Caps On Hep C Products
This article was originally published in Scrip
India has announced its national list of essential medicines (NLEM) 2015, which covers a total of 376 drugs across 30 therapeutic segments, including those such as sofosbuvir, pegylated interferon alfa 2a and 2b, raltegravir, trastuzumab, and rituximab, as against 348 medicines across 27 segments listed in NLEM 2011.
You may also be interested in...
India’s national list of essential medicines 2022 features 34 additions, including insulin glargine, teneligliptin, lenalidomide, bedaquiline and montelukast, with price control expected to follow on these drugs.
GSK discontinues Cervarix in India as part of portfolio rationalization efforts against the backdrop of the arrival of Serum’s 'affordable' quadrivalent HPV vaccine. The heat is also believed to be on the UK drugmaker’s pneumococcal vaccine Synflorix in the country.
Indegene’s chief technology officer, Tarun Mathur, talks to Scrip about blockchain’s potential in a number of areas across pharma’s operations including the clinical supply chain and trials as well as its role in enabling improved trust in the healthcare data ecosystem.